XML 18 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Cash Flows from Operating Activities:        
Net loss $ (381,890) $ (296,439) $ (1,178,793) $ (1,160,638)
Adjustments to reconcile net loss to net cash used in operating activities -        
Depreciation and amortization 5,541 3,888 21,271 20,020
Gain on sale of assets (1,566) (15,282) (27,075) (14,028)
Stock-based compensation expense 100,323 27,000 125,675 141,033
Non-cash consulting expense 4,500 11,250 66,750 64,507
Non-cash gain on settlement of liabilities by issuing common stock     (35,172) 0
Changes in operating assets and liabilities -        
Accounts receivable, net 128,914 (149,252) (56,993) (252,349)
Inventories 54,529 76,929 (84,378) (92,705)
Prepaid expenses 7,194 18,346 26,740 (30,355)
Accounts payable (40,809) (244,207) 210,958 425,937
Customer advances 3,500 (25,780) 92,600 (11,844)
Accrued expenses (5,320) 2,391 64,624 24,391
Net cash used in operating activities (125,084) (591,156) (773,793) (886,031)
Cash Flows from Investing Activities:        
Additional patent costs (1,443) (851) (10,972) (8,524)
Purchases of property and equipment (4,372) (31,736) (62,418) (1,680)
Proceeds from sale of assets 1,566 15,282 27,075 14,028
Net cash used in investing activities (4,249) (17,305) (46,315) 3,824
Cash Flows from Financing Activities:        
Gross proceeds from July 2014 private placement of common stock 0 980,291 980,291 50,000
Private placement expenses incurred and paid as of September 30, 2015 0 (46,719) (121,512) 0
Net cash provided by financing activities 0 933,572 858,779 50,000
Net increase (decrease) in cash and cash equivalents (129,333) 325,111 38,671 (832,207)
Cash and cash equivalents, beginning of period 241,051 202,380 202,380 1,034,587
Cash and cash equivalents, end of period 111,718 527,491 241,051 202,380
Supplemental Disclosure of Cash Flow Informatin:        
Cash paid for income taxes 912 912 912 912
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:        
Issuance of 90,298 shares of common stock to consultants $ 0 $ 65,016 $ 126,643 $ 0